Metabolic+
Weight Loss Program
Metabolic+ Weight Loss Overview
Feminyn’s Metabolic+ combines medical expertise, science-backed support, and compassionate care to help you achieve sustainable weight loss. Our team leverages the latest advances with a focus on your unique biology.
From customized medication options to ongoing, expert guidance, we ensure every step of your journey is personalized. Join the program trusted by women for proven results and lasting wellness.
Clinician-Trusted Weight Loss Medications
Compounded Semaglutide
Starting at $179/mo*
Semaglutide supports appetite control and steady metabolic regulation.
It is commonly chosen by patients who prefer a gradual, predictable response.
Tirzepatide supports appetite control with dual targeting of metabolic pathways.
It is often selected by patients seeking a more dynamic metabolic response.
Ozempic® (semaglutide) activates GLP-1 receptors to support appetite control and healthier blood-sugar patterns. It is used together with nutrition and movement plans to help eligible adults lose weight over time.
Zepbound® (tirzepatide) targets both GIP and GLP-1 receptors to support appetite regulation and metabolic efficiency. Its dual-hormone action is designed to help eligible adults lose weight when combined with sustainable lifestyle changes.
*With a 12-month plan paid upfront in full. Actual price to customer will depend on product and subscription plan purchased.
Compounded drugs are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA.
Medication options shown are for informational and educational purposes only. Selecting a medication does not constitute a prescription request and does not guarantee that the medication will be prescribed. All patients are required to complete a medical intake and undergo an evaluation by a licensed healthcare provider. Any decision to prescribe, modify, or decline treatment is made independently by the provider based on clinical judgment and individual medical appropriateness.
Ozempic® (semaglutide) and Zepbound® (tirzepatide) are not compounded. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Zepbound® is FDA-approved for weight loss. Ozempic® is a registered trademark of Novo Nordisk A/S. Zepbound® is a registered trademark of Eli Lilly and Company. Feminyn LLC is not affiliated or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
Weight Loss Treatment Options
Compounded drug products are not FDA-approved. FDA does not evaluate compounded products for safety, effectiveness, or quality.
Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate.
What To Expect With Metabolic+
Clinician-guided care designed to support appetite regulation, energy, and metabolic health—based on your individual biology.
Treatment begins with a short intake to understand your health history, goals, and metabolic profile. If appropriate, a licensed clinician develops a personalized plan and adjusts care over time based on your response.
No restrictive dieting. No one-size-fits-all protocols. Just evidence-based support that adapts as your body changes.
92%
Member Success
4.9
Clinician Rating
50
States Covered
Frequently Asked Questions
Is Metabolic+ Is Right For You?
Begin a short intake to evaluate your metabolic health and treatment options.
